1. Home
  2. FAMI vs AIMD Comparison

FAMI vs AIMD Comparison

Compare FAMI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$0.97

Market Cap

16.7M

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.87

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
AIMD
Founded
2015
1984
Country
China
United States
Employees
N/A
41
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.7M
17.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FAMI
AIMD
Price
$0.97
$1.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
51.1K
983.0K
Earning Date
08-04-2025
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.45
52 Week High
$2.12
$4.50

Technical Indicators

Market Signals
Indicator
FAMI
AIMD
Relative Strength Index (RSI) 43.79 47.51
Support Level N/A $1.77
Resistance Level $1.48 $2.51
Average True Range (ATR) 0.17 0.23
MACD 0.00 -0.04
Stochastic Oscillator 37.28 15.50

Price Performance

Historical Comparison
FAMI
AIMD

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe and the Middle East under the Forasen and Farmmi brands.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: